Among 7697 consecutive patients with multivessel coronary artery disease, MI rates after PCI were 18.7%, 3.2%, and 5.5% with the second universal definition of MI (UDMI), third UDMI, and the Society ...

Nearly 3 years ago, the CHAMPION trials found that the novel antiplatelet cangrelor failed to reduce ischemic events compared with clopidogrel in the context of percutaneous coronary intervention (PCI ...

In patients at high bleeding risk who had undergone percutaneous coronary intervention (PCI), 1 month of dual antiplatelet therapy (DAPT) was associated with a similar rate of major adverse cardiac or ...

The procedural success of chronic total occlusion (CTO) PCI has been steadily increasing despite rising lesion complexity, according to new observational data derived from centers across Europe. “CTO ...

It is not known whether prehospital fibrinolysis, coupled with timely coronary angiography, provides a clinical outcome similar to that with primary percutaneous coronary intervention (PCI) early ...